National Unified Renal Translational Research Enterprise: Idiopathic Nephrotic Syndrome (NURTuRE-INS) study.

biobank focal segmental glomerulosclerosis idiopathic nephrotic syndrome minimal change disease

Journal

Clinical kidney journal
ISSN: 2048-8505
Titre abrégé: Clin Kidney J
Pays: England
ID NLM: 101579321

Informations de publication

Date de publication:
Aug 2024
Historique:
received: 29 01 2024
medline: 13 8 2024
pubmed: 13 8 2024
entrez: 13 8 2024
Statut: epublish

Résumé

Idiopathic nephrotic syndrome (INS) is a heterogenous disease and current classification is based on observational responses to therapies or kidney histology. The National Unified Renal Translational Research Enterprise (NURTuRE)-INS cohort aims to facilitate novel ways of stratifying INS patients to improve disease understanding, therapeutics and design of clinical trials. NURTuRE-INS is a prospective cohort study of children and adults with INS in a linked biorepository. All recruits had at least one sampling visit collecting serum, plasma, urine and blood for RNA and DNA extraction, frozen within 2 hours of collection. Clinical histology slides and biopsy tissue blocks were also collected. A total of 739 participants were recruited from 23 centres to NURTuRE-INS, half of whom were diagnosed in childhood [ NURTuRE-INS is a prospective cohort study with high-quality biosamples and longitudinal data that will assist research into the mechanistic stratification of INS. Samples and data will be available through a Strategic Access and Oversight Committee.

Sections du résumé

Background UNASSIGNED
Idiopathic nephrotic syndrome (INS) is a heterogenous disease and current classification is based on observational responses to therapies or kidney histology. The National Unified Renal Translational Research Enterprise (NURTuRE)-INS cohort aims to facilitate novel ways of stratifying INS patients to improve disease understanding, therapeutics and design of clinical trials.
Methods UNASSIGNED
NURTuRE-INS is a prospective cohort study of children and adults with INS in a linked biorepository. All recruits had at least one sampling visit collecting serum, plasma, urine and blood for RNA and DNA extraction, frozen within 2 hours of collection. Clinical histology slides and biopsy tissue blocks were also collected.
Results UNASSIGNED
A total of 739 participants were recruited from 23 centres to NURTuRE-INS, half of whom were diagnosed in childhood [
Conclusions UNASSIGNED
NURTuRE-INS is a prospective cohort study with high-quality biosamples and longitudinal data that will assist research into the mechanistic stratification of INS. Samples and data will be available through a Strategic Access and Oversight Committee.

Identifiants

pubmed: 39135942
doi: 10.1093/ckj/sfae096
pii: sfae096
pmc: PMC11317841
doi:

Types de publication

Journal Article

Langues

eng

Pagination

sfae096

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the ERA.

Déclaration de conflit d'intérêts

M.W.T. reports consulting fees from Boehringer Ingelheim, honoraria and support to attend conferences from Bayer and a leadership role in the International Society of Nephrology. M.A.S. reports consulting fees from Travere and Purespring Therapeutics. R.E.B. reports grant funding and a patent with Randox Laboratories and support for attending meetings from Kidney Research UK. T.J. reports previous salary from UCB, consulting fees from UCB and Hybridize Therapeutics and shares in UCB. M.N reports a position on the QUOD Steering Committee. R.U. reports consulting fees from and stock in AstraZeneca and a leadership position in the Faculty of Pharmaceutical Medicine, Royal College of Physicians (London). The other authors declare that they have no competing interests.

Auteurs

Elizabeth Colby (E)

Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK.

Samantha Hayward (S)

Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK.
MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.

Melissa Benavente (M)

Centre for Kidney Research and Innovation, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.

Fiona Robertson (F)

Centre for Kidney Research and Innovation, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.

Agnieszka Bierzynska (A)

Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK.

Amy Osborne (A)

Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK.

Kevon Parmesar (K)

Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK.

Maryam Afzal (M)

Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK.

Tracey Chapman (T)

Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK.

Fatima Ullah (F)

Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK.

Elaine Davies (E)

Kidney Research UK, Peterborough, UK.

Michael Nation (M)

Kidney Research UK, Peterborough, UK.

Wendy Cook (W)

Nephrotic Syndrome Trust, Somerset, UK.

Tim Johnson (T)

Experimental Renal Medicine, Medical School, University of Sheffield, Sheffield, UK.

Uwe Andag (U)

Metabolic Disease and Bioinformatics, Evotec International GmbH, Hamburg, Germany.

Olivier Radresa (O)

Metabolic Disease and Bioinformatics, Evotec International GmbH, Hamburg, Germany.

Philipp Skroblin (P)

Metabolic Disease and Bioinformatics, Evotec International GmbH, Hamburg, Germany.

Michaela Bayerlova (M)

Metabolic Disease and Bioinformatics, Evotec International GmbH, Hamburg, Germany.

Robert Unwin (R)

Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Nicolas Vuilleumier (N)

Division of Laboratory Medicine, Diagnostics Department and Department of Medicine Specialties, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.

Rosamonde E Banks (RE)

Leeds Institute of Medical Research at St James's, School of Medicine, University of Leeds, Leeds, UK (now Emerita position).

Fiona Braddon (F)

UK Renal Registry, Bristol, UK.

Ania Koziell (A)

Department of Experimental Immunobiology, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Department of Paediatric Nephrology, Evelina London, Guy's and St Thomas' NHS Trust, London, UK.

Maarten W Taal (MW)

Centre for Kidney Research and Innovation, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.
Department of Renal Medicine, Royal Derby Hospital, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.

Gavin I Welsh (GI)

Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK.

Moin A Saleem (MA)

Bristol Renal, Bristol Medical School, University of Bristol, Bristol, UK.

Classifications MeSH